FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Ammonium lactate | Ammonium lactate 120 mg/g | CreamTopical | Zydus Lifesciences Limited | Oct 2, 2026 | 70771-1988 |
| Guanfacine ERguanfacine | Guanfacine hydrochloride 1 mg/1 | Tablet, Extended releaseOral | Direct_Rx | Oct 2, 2026 | 72189-693 |
| Ammonium lactate | Ammonium lactate 120 mg/g | CreamTopical | Viona Pharmaceuticals Inc | Oct 2, 2026 | 72578-203 |
| Sdamloamlodipine | Amlodipine besylate 2.5 mg/2.5mg | SolutionOral | Pangea Pharmaceuticals, LLC | Oct 2, 2026 | 81279-133 |
| Sdamloamlodipine | Amlodipine besylate 10 mg/10mg | SolutionOral | Pangea Pharmaceuticals, LLC | Oct 2, 2026 | 81279-135 |
| Valacyclovir Hydrochloride | Valacyclovir hydrochloride 1 g/1 | Tablet, Film coatedOral | Northwind Health Company, LLC | Oct 2, 2026 | 82868-117 |
| Perampanel | Perampanel 2 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-084 |
| Perampanel | Perampanel 4 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-085 |
| Perampanel | Perampanel 6 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-086 |
| Perampanel | Perampanel 8 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-087 |
| Perampanel | Perampanel 10 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-088 |
| Perampanel | Perampanel 12 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | Oct 2, 2026 | 84386-089 |
| Utebzitebipenem pivoxil | Tebipenem pivoxil hydrobromide 300 mg/1 | Tablet, Film coatedOral | GlaxoSmithKline LLC | Oct 1, 2026 | 0173-0956 |
| Lactated Ringerssodium chloride, sodium lactate, potassium chloride, and calcium chloride | Sodium chloride .6 g/100mL + 3 more ingredients | Injection, SolutionIntravenous | B. Braun Medical Inc. | Oct 1, 2026 | 0264-7500 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Oct 1, 2026 | 0781-2731 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Oct 1, 2026 | 0781-2732 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Oct 1, 2026 | 0781-2733 |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Sandoz Inc | Oct 1, 2026 | 0781-2734 |
| Claforancefotaxime | Cefotaxime sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | SteriMax Inc. | Oct 1, 2026 | 21586-031 |
| Gentamicin Sulfate | Gentamicin sulfate 1 mg/g | OintmentTopical | Encube Ethicals, Inc. | Oct 1, 2026 | 21922-110 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 60 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-322 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 90 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-323 |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-324 |
| Topiramate | Topiramate 25 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-325 |
| Topiramate | Topiramate 50 mg/1 | Capsule, Extended releaseOral | Cranbury Pharmaceuticals, LLC | Oct 1, 2026 | 27808-326 |